Genetic Polymorphisms of CYP2C9/CYP2C19 in Chronic Obstructive Pulmonary Disease

References

• Li JX , Fu WP , Zhang J , et al. A functional SNP upstream of the ADRB2 gene is associated with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:917–925. doi:10.2147/COPD.S151153.
   PubMed Web of Science ®Google Scholar
• Cho MH , McDonald ML , Zhou X , et al. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med. 2014;2(3):214–225. doi:10.1016/S2213-2600(14)70002-5.
   PubMed Web of Science ®Google Scholar
• Wang Y , Zhou Q , Dong L , et al. The effects of CXCL10 polymorphisms on COPD susceptibility. Mol Genet Genomics. 2018;293(3):649–655. doi:10.1007/s00438-017-1408-z.
   PubMed Web of Science ®Google Scholar
• McCloskey SC , Patel BD , Hinchliffe SJ , et al. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med. 2001;164(8):1419–1424. doi:10.1164/ajrccm.164.8.2105002.
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen T , Thomsen SF , Vestbo J , et al. Genetic influences on chronic obstructive pulmonary disease – a twin study. Respir Med. 2010;104(12):1890–1895. doi:10.1016/j.rmed.2010.05.004.
   PubMed Web of Science ®Google Scholar
• Ding Y , Niu H , Zhou L , et al. Association of multiple genetic variants with chronic obstructive pulmonary disease susceptibility in Hainan region. Clin Respir J. 2017;11(6):727–732. doi:10.1111/crj.12407.
   PubMed Web of Science ®Google Scholar
• Ding Y , Yang D , Zhou L , et al. Variants in multiple genes polymorphism association analysis of COPD in the Chinese Li population. Int J Chron Obstruct Pulmon Dis. 2015;10:1455–1463. doi:10.2147/COPD.S86721.
   PubMed Web of Science ®Google Scholar
• Ding Y , Niu H , Yang H , et al. EGLN2 and RNF150 genetic variants are associated with chronic obstructive pulmonary disease risk in the Chinese population. Int J Chron Obstruct Pulmon Dis. 2015;10:145–151. doi:10.2147/COPD.S73031.
   PubMed Web of Science ®Google Scholar
• Bylund J , Ericsson J , Oliw EH . Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography-mass spectrometry with ion trap MS. Anal Biochem. 1998;265(1):55–68. doi:10.1006/abio.1998.2897.
   PubMed Web of Science ®Google Scholar
• Bertrand-Thiebault C , Berrahmoune H , Thompson A , et al. Genetic polymorphism of CYP2C19 gene in the Stanislas cohort. A link with inflammation. Ann Hum Genet. 2008;72(Part 2):178–183. doi:10.1111/j.1469-1809.2007.00417.x.
   PubMedGoogle Scholar
• Shahabi P , Siest G , Meyer UA , et al. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders. Pharmacol Ther. 2014;144(2):134–161. doi:10.1016/j.pharmthera.2014.05.011.
   PubMed Web of Science ®Google Scholar
• Enayetallah AE , French RA , Thibodeau MS , et al. Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem. 2004;52(4):447–454. doi:10.1177/002215540405200403.
   PubMed Web of Science ®Google Scholar
• Office of the Surgeon General, Office on Smoking and Health. The health consequences of smoking: a report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention (US); 2004. (Reports of the Surgeon General).
   Google Scholar
• Kaur-Knudsen D , Bojesen SE , Nordestgaard BG . Cytochrome P450 1B1 and 2C9 genotypes and risk of ischemic vascular disease, cancer, and chronic obstructive pulmonary disease. Curr Vasc Pharmacol. 2012;10(4):512–520. doi:10.2174/157016112800812746.
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF , Criner GJ , Martinez FJ , et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP.
   PubMed Web of Science ®Google Scholar
• Salvi S . Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):17–27. doi:10.1016/j.ccm.2013.09.011.
   PubMed Web of Science ®Google Scholar
• Postma DS , Bush A , van den Berge M . Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015;385(9971):899–909. doi:10.1016/S0140-6736(14)60446-3.
   PubMed Web of Science ®Google Scholar
• Guengerich FP , Waterman MR , Egli M . Recent structural insights into cytochrome P450 function. Trends Pharmacol Sci. 2016;37(8):625–640. doi:10.1016/j.tips.2016.05.006.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S , Sinha K , Sil PC . Cytochrome P450s: mechanisms and biological implications in drug metabolism and its interaction with oxidative stress. Curr Drug Metab. 2014;15(7):719–742. doi:10.2174/1389200215666141125121659.
   PubMed Web of Science ®Google Scholar
• Cheng SL , Yu CJ , Yang PC . Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease. Biochem Genet. 2009;47(7–8):591–601. doi:10.1007/s10528-009-9252-4.
   PubMed Web of Science ®Google Scholar
• Yang L , Li F , Yan M , et al . Association of the CYP1A1 MspI and TNFα-308 polymorphisms with chronic obstructive pulmonary disease in Inner Mongolia. Genet Mol Res. 2014;13(2):3209–3217. doi:10.4238/2014.April.25.6.
   PubMed Web of Science ®Google Scholar
• Wang CD , Chen N , Huang L , et al. Impact of cyp1a1 polymorphisms on susceptibility to chronic obstructive pulmonary disease: a meta-analysis. Biomed Res Int. 2015;2015:942958. doi:10.1155/2015/942958.
   PubMed Web of Science ®Google Scholar
• Seo T , Pahwa P , McDuffie HH , et al. Association between cytochrome P450 3A5 polymorphism and the lung function in Saskatchewan grain workers. Pharmacogenet Genomics. 2008;18(6):487–493. doi:10.1097/FPC.0b013e3282fb02ba.
   PubMed Web of Science ®Google Scholar
• Polonikov A , Kharchenko A , Bykanova M , et al. Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population. Gene. 2017;627:451–459. doi:10.1016/j.gene.2017.07.004.
   PubMed Web of Science ®Google Scholar
• Fortuny J , Kogevinas M , Garcia-Closas M , et al. Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1696–1702. doi:10.1158/1055-9965.EPI-06-0038.
   PubMed Web of Science ®Google Scholar
• Kamata S , Fujino N , Yamada M , et al. Expression of cytochrome P450 mRNAs in Type II alveolar cells from subjects with chronic obstructive pulmonary disease. Pharmacol Res Perspect. 2018;6(3):e00405. doi:10.1002/prp2.405.
   PubMed Web of Science ®Google Scholar
• Spector AA , Norris AW . Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol. 2007;292(3):C996–1012. doi:10.1152/ajpcell.00402.2006.
   PubMed Web of Science ®Google Scholar
• Li Y , Yu G , Yuan S , et al. 14,15-Epoxyeicosatrienoic acid suppresses cigarette smoke condensate-induced inflammation in lung epithelial cells by inhibiting autophagy. Am J Physiol Lung Cell Mol Physiol. 2016;311(5):L970–L980. doi:10.1152/ajplung.00161.2016.
   PubMed Web of Science ®Google Scholar
• Li Y , Yu G , Yuan S , et al. Cigarette smoke-induced pulmonary inflammation and autophagy are attenuated in Ephx2-Deficient mice. Inflammation. 2017;40(2):497–510. doi:10.1007/s10753-016-0495-z.
   PubMed Web of Science ®Google Scholar